z-logo
Premium
Clinical outcomes for couples containing a reciprocal chromosome translocation carrier without preimplantation genetic diagnosis
Author(s) -
Yin Biao,
Zhu Yuanchang,
Wu Tonghua,
Shen Shuqiu,
Zeng Yong,
Liang Desheng
Publication year - 2017
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1002/ijgo.12062
Subject(s) - intracytoplasmic sperm injection , preimplantation genetic diagnosis , in vitro fertilisation , assisted reproductive technology , chromosomal translocation , randomized controlled trial , gynecology , medicine , pregnancy , obstetrics , pregnancy rate , andrology , abortion , robertsonian translocation , karyotype , chromosome , biology , infertility , genetics , gene
Objective To evaluate the pregnancy outcomes of couples containing a carrier of a reciprocal chromosome translocation ( RCT ) after assisted reproductive technology without preimplantation genetic diagnosis. Methods A retrospective study was performed using data for couples with an RCT carrier and control couples with a normal karyotype (1:4 ratio) who underwent assisted reproductive technology cycles at a Chinese fertility center in 2010–2011. The embryos were fertilized via in vitro fertilization ( IVF ) or intracytoplasmic sperm injection ( ICSI ). Only the first pick‐up cycles were used for analysis. Clinical variables were compared. Results Compared with the control group (n=164), the RCT group (n=41) had a marginally lower clinical pregnancy rate (46.3% [19/41] vs 54.3% [89/164]), implantation rate (21.7% [23/106] vs 26.9% [118/438]), multiple‐gestation pregnancy rate (21.1% [4/19] vs 32.6% [29/89]), and delivery rate (36.6% [15/41] vs 47.6% [78/164]), whereas the spontaneous abortion rate was slightly higher (21.1% [4/19] vs 12.4% [11/89]). However, none of these differences were significant. Conclusion The clinical outcomes for RCT carriers were acceptable after IVF / ICSI without performing preimplantation genetic diagnosis, indicating that this approach might comprise a feasible alternative fertility treatment for RCT carriers.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom